Literature DB >> 23161257

Progress and prospects in neurorehabilitation: clinical applications of stem cells and brain-computer interface for spinal cord lesions.

Mariana Gongora1, Caroline Peressutti, Sergio Machado, Silmar Teixeira, Bruna Velasques, Pedro Ribeiro.   

Abstract

Spinal cord injury (SCI) is a disease that affects millions of people worldwide, causing a temporary or permanent impairment of neuromotor functions. Mostly associated to traumatic lesions, but also to other forms of disease, the appropriate treatment is still unsure. In this review, several ongoing studies are presented that aim to provide methods of prevention that ensure quality of life, and rehabilitation trends to patients who suffer from this injury. Stem cell research, highlighted in this review, seeks to reduce damage caused to the tissue, as also provide spinal cord regeneration through the application of several types of stem cells. On the other hand, research using brain-computer interface (BCI) technology proposes the development of interfaces based on the interaction of neural networks with artificial tools to restore motor control and full mobility of the injured area. PubMed, MEDLINE and SciELO data basis analyses were performed to identify studies published from 2000 to date, which describe the link between SCI with stem cells and BCI technology.

Entities:  

Mesh:

Year:  2012        PMID: 23161257     DOI: 10.1007/s10072-012-1232-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  53 in total

1.  'Thought'--control of functional electrical stimulation to restore hand grasp in a patient with tetraplegia.

Authors:  Gert Pfurtscheller; Gernot R Müller; Jörg Pfurtscheller; Hans Jürgen Gerner; Rüdiger Rupp
Journal:  Neurosci Lett       Date:  2003-11-06       Impact factor: 3.046

2.  Bone marrow stromal cells enhance differentiation of cocultured neurosphere cells and promote regeneration of injured spinal cord.

Authors:  Sufan Wu; Yoshihisa Suzuki; Yoko Ejiri; Toru Noda; Hongliang Bai; Masaaki Kitada; Kazuya Kataoka; Masayoshi Ohta; Hirotomi Chou; Chizuka Ide
Journal:  J Neurosci Res       Date:  2003-05-01       Impact factor: 4.164

Review 3.  Brain-machine interfaces: past, present and future.

Authors:  Mikhail A Lebedev; Miguel A L Nicolelis
Journal:  Trends Neurosci       Date:  2006-07-21       Impact factor: 13.837

Review 4.  Stem cells and spinal cord regeneration.

Authors:  Sharyn L Rossi; Hans S Keirstead
Journal:  Curr Opin Biotechnol       Date:  2009-10       Impact factor: 9.740

Review 5.  Progress and prospects: stem cells and neurological diseases.

Authors:  S Gögel; M Gubernator; S L Minger
Journal:  Gene Ther       Date:  2010-09-30       Impact factor: 5.250

6.  Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation.

Authors:  Gabriel I Nistor; Minodora O Totoiu; Nadia Haque; Melissa K Carpenter; Hans S Keirstead
Journal:  Glia       Date:  2005-02       Impact factor: 7.452

7.  Plasticity associated changes in cortical somatosensory evoked potentials following spinal cord injury in rats.

Authors:  Faith A Bazley; Angelo H All; Nitish V Thakor; Anil Maybhate
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2011

Review 8.  Human mesenchymal stem cells: from basic biology to clinical applications.

Authors:  B M Abdallah; M Kassem
Journal:  Gene Ther       Date:  2007-11-08       Impact factor: 5.250

9.  Pre-differentiated embryonic stem cells promote neuronal regeneration by cross-coupling of BDNF and IL-6 signaling pathways in the host tissue.

Authors:  Margarita Glazova; Elena S Pak; Justin Moretto; Sarah Hollis; Kori L Brewer; Alexander K Murashov
Journal:  J Neurotrauma       Date:  2009-07       Impact factor: 5.269

10.  Continuous three-dimensional control of a virtual helicopter using a motor imagery based brain-computer interface.

Authors:  Alexander J Doud; John P Lucas; Marc T Pisansky; Bin He
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.